[Advances in Janus kinase/signal transducer and activator of transcription signaling pathway and its targeted drugs in dermatosis and immune diseases].

Lu, C F; Leng, X M

Lu, C F; Leng, X M.

Afiliación

Lu CF; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
Leng XM; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.

Zhonghua Nei Ke Za Zhi ; 61(7): 827-831, 2022 Jul 01.

Article en Zh | MEDLINE | ID: mdl-35764571

Asunto(s)

Enfermedades del Sistema Inmune; Enfermedades de la Piel; Humanos; Janus Quinasa 2/metabolismo; Quinasas Janus/metabolismo; Transducción de Señal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Enfermedades del Sistema Inmune Límite: Humans Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google